Growth conditions of clostridium perfringens type B for production of toxins used to obtain veterinary vaccines
Author(s) -
Igor Viana Brandi,
O. D. Mozzer,
Edson Vander Jorge,
Frederico José Vieira Passos,
Flávia Maria Lopes Passos,
Alex Sander Rodrigues Cangussu,
Eliane Macedo Sobrinho
Publication year - 2014
Publication title -
bioprocess and biosystems engineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.628
H-Index - 68
eISSN - 1615-7605
pISSN - 1615-7591
DOI - 10.1007/s00449-014-1146-0
Subject(s) - clostridium perfringens , fermentation , food science , industrial and production engineering , chemistry , lactic acid , toxin , acetic acid , metabolite , clostridium , microbiology and biotechnology , ethanol , industrial fermentation , biochemistry , biology , bacteria , genetics , electrical engineering , engineering
The diseases caused for Clostridium perfringens are generically called enterotoxemias because toxins produced in the intestine may be absorbed into the general circulation. C. perfringens type B, grown in batch fermentation, produced toxins used to obtain veterinary vaccines. Glucose in concentrations of 1.4-111.1 mM was used to define the culture medium. The minimum concentration for a satisfactory production of vaccines against clostridial diseases was 55.6 mM. Best results were brought forth by meat and casein peptones, both in the concentration 5.0 g l(-1) in combination with glucose and a culture pH maintained at 6.5 throughout the fermentation process. The production of lactic, acetic and propionic organic acids was observed. Ethanol was the metabolite produced in the highest concentration when cultures maintained steady pH of 6.5 with exception of cultures with initial glucose concentration of 1.4 mM, where the highest production was of propionic acid. Maximal cell concentration and the highest toxin title concomitantly low yield coefficient to organic acids and ethanol were obtained using basal medium containing 111.1 mM glucose under a controlled pH culture (pH) 6.5 in batch fermentations of C. perfringens type B. These data contribute to improve process for industrial toxin production allowing better condition to produce a toxoid vaccine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom